Precision proteoform design for 4R tau isoform selective templated aggregation

Andrew P. Longhini, Austin DuBose, Samuel Lobo, Vishnu Vijayan, Yeran Bai, Erica Keane Rivera, Julia Sala-Jarque, Arina Nikitina, Daniel C. Carrettiero, Matthew T. Unger, Olivia R. Sclafani, Valerie Fu, Emily R. Beckett, Michael Vigers, Luc Buée, Isabelle Landrieu, Scott Shell, Joan E. Shea, Songi Han*, Kenneth S. Kosik*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Prion-like spread of disease-specific tau conformers is a hallmark of all tauopathies. A 19-residue probe peptide containing a P301L mutation and spanning the R2/R3 splice junction of tau folds and stacks into seeding-competent fibrils and induces aggregation of 4R, but not 3R tau. These tau peptide fibrils propagate aggregated intracellular tau over multiple generations, have a high β-sheet content, a colocalized lipid signal, and adopt a well-defined U-shaped fold found in 4R tauopathy brain-derived fibrils. Fully atomistic replica exchange molecular dynamics (MD) simulations were used to compute the free energy landscapes of the conformational ensemble of the peptide monomers. These identified an aggregation-prohibiting β-hairpin structure and an aggregation-competent U-fold unique to 4R tauopathy fibrils. Guided by MD simulations, we identified that the N-terminal-flanking residues to PHF6, which slightly vary between 4R and 3R isoforms, modulate seeding. Strikingly, when a single amino acid switch at position 305 replaced the serine of 4R tau with a lysine from the corresponding position in the first repeat of 3R tau, the seeding induced by the 19-residue peptide was markedly reduced. Conversely, a 4R tau mimic with three repeats, prepared by replacing those amino acids in the first repeat with those amino acids uniquely present in the second repeat, recovered aggregation when exposed to the 19-residue peptide. These peptide fibrils function as partial prions to recruit naive 4R tau-ten times the length of the peptide-and serve as a critical template for 4R tauopathy propagation. These results hint at opportunities for tau isoform-specific therapeutic interventions.

Original languageEnglish (US)
Article numbere2320456121
JournalProceedings of the National Academy of Sciences of the United States of America
Volume121
Issue number15
DOIs
StatePublished - Apr 9 2024

Funding

We acknowledge support by the NIH grant 5R01AG056058-07 and the Rainwater Foundation. We acknowledge support from the Center for Scientific Computing at the California Nanosystems Institute (CNSI, NSF grant CNS-1725797) for the availability of high-performance computing resources and support. This work used the Extreme Science and Engineering Discovery Environment, which is supported by the NSF grant ACI-1548562 (MCA05S027). J.E.S. acknowledges support from the NSF (MCB-1716956). We acknowledge support from the W. M. Keck Foundation. We acknowledge the use of the NRI-MCDB Microscopy Facility and the Resonant Scanning Confocal supported by NSF MRI grant DBI-1625770. ACKNOWLEDGMENTS. We acknowledge support by the NIH grant 5R01AG056058-07 and the Rainwater Foundation. We acknowledge support from the Center for Scientific Computing at the California Nanosystems Institute (CNSI, NSF grant CNS-1725797) for the availability of high-performance computing resources and support. This work used the Extreme Science and Engineering Discovery Environment, which is supported by the NSF grant ACI-1548562 (MCA05S027). J.E.S. acknowledges support from the NSF (MCB-1716956). We acknowledge support from the W. M. Keck Foundation. We acknowledge the use of the NRI-MCDB Microscopy Facility and the Resonant Scanning Confocal supported by NSF MRI grant DBI-1625770.

Keywords

  • amyloidogenic core
  • prion-like templating
  • protein misfolding
  • tauopathies

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Precision proteoform design for 4R tau isoform selective templated aggregation'. Together they form a unique fingerprint.

Cite this